Alternative Investments

Valuing Royalty Streams and Decay Curves

A royalty stream is valued by projecting future royalty income, which usually declines along a decay curve after an initial peak, and discounting it at a rate that reflects the asset's risk. The key inputs are current earnings, the shape and pace of decay, the long term floor, contract terms, collection risk and the discount rate.

What is a royalty stream?

A royalty is a right to receive a share of revenue generated by someone else's use of an asset. Common examples include music publishing and recorded music catalogs, pharmaceutical and medical device royalties, technology licenses, franchise fees, film and television libraries, mineral and energy interests and brand licenses. The holder typically has no operating costs and no control over the underlying business, so cash flow depends on the licensee's sales and the terms of the royalty agreement. That passive profile makes royalties attractive to investors seeking income that is less correlated with broad markets, but it also means the holder must understand the underlying asset well enough to forecast its revenue path.

Royalty valuation differs from operating company valuation in two ways. First, there is usually no reinvestment, so nearly all income is distributable. Second, income often declines predictably over time as a product ages, a patent expires or a song moves from new release to catalog, so modeling the decay is the core analytical task. Understanding where each asset sits in its life cycle is therefore the starting point for any credible valuation, whether for an acquisition, a financing or a portfolio mark.

How do decay curves work?

A decay curve describes how royalty income changes as an asset ages. Many creative assets follow a pattern of high income at release, steep declines over the first few years, and then slower declines that approach a relatively stable long tail. Pharmaceutical royalties often rise during launch, plateau during the patent protected period and then fall sharply at loss of exclusivity. Energy royalties follow the production decline of the underlying wells. The analyst's job is to place each asset on its curve and estimate how much decline remains.

Decay is best modeled from the asset's own history and from comparable assets at similar ages. A catalog of older works that has already passed its steep decline phase deserves a different curve than a catalog of recent releases. Weighting the portfolio by age, genre or product type and applying a separate curve to each segment produces a more reliable forecast than a single average rate applied to everything. Analysts should also separate one time events, such as a sync placement or a renewed license, from recurring income before fitting a curve.

How should the discount rate be chosen?

The discount rate should reflect the uncertainty of the cash flows, the illiquidity of the asset and the cost of capital for buyers in that market. Factors that raise the rate include short or volatile earnings history, concentration in a few titles or products, reliance on a single licensee, legal uncertainty over ownership or rights, and sensitivity to changes in distribution technology or pricing. Factors that lower it include long, stable histories, broad diversification, creditworthy payors and contractual floors. Some practitioners also add a premium for the cost and complexity of administering rights and auditing payors.

Discount rates and decay assumptions interact. A buyer can justify a high price either with a low discount rate or with a slow decay assumption, so an analyst should examine both together. A useful check is the implied multiple of current annual royalty income, which can be compared with observed transaction multiples, while recognizing that market multiples may embed assumptions the analyst does not share. If both are aggressive at once, the resulting value can look reasonable on a multiple basis while depending heavily on assumptions that have little historical support.

How is terminal value handled for long tail assets?

Many royalties have no fixed end date within a typical forecast horizon. Copyrights can last for decades and some mineral interests for longer. After an explicit forecast period, analysts usually estimate a terminal value by assuming income declines at a constant rate in perpetuity, which uses a growing perpetuity formula with a negative growth rate. When the asset has a definite end, such as patent expiry or a contract term, the terminal value should reflect only the remaining years. Analysts should also confirm whether contractual or statutory reversion rights could end the income stream earlier than expected.

Terminal value can be a large share of the total, so its assumptions deserve as much scrutiny as the explicit years. A small change in the long term decline rate or discount rate can move the valuation considerably. Analysts should test whether the implied income decades from now is plausible given changes in consumption patterns, technology and rights reversion provisions. Presenting value with and without terminal value, alongside the payback period of the purchase price from explicit cash flow alone, gives an investment committee a clearer sense of how much of the price depends on the distant future.

What risks are unique to royalty investments?

Royalty holders face risks that ordinary financial models do not capture. Rights risk arises when chain of title is unclear, when rights revert to creators after a statutory period, or when licenses permit renegotiation. Counterparty risk exists because the holder depends on the licensee or collecting society to report and pay accurately, so audit rights matter. Technology and distribution risk can change per unit economics quickly, as rate setting decisions, platform pricing or market shifts alter the royalty paid per use. Pharmaceutical royalties face clinical, regulatory, competitive and patent litigation risk. Energy royalties face commodity price and production risk. Each of these belongs explicitly in the downside case rather than being buried in a higher discount rate.

• Chain of title, rights reversion and contract renegotiation
• Licensee reporting accuracy and audit rights
• Distribution and pricing changes that alter per unit royalties
• Patent expiry, competition and litigation for life sciences assets
• Commodity prices and production decline for energy interests

How are royalties financed and underwritten by lenders?

Lenders finance royalty portfolios by advancing against projected cash flow, often through special purpose vehicles that own the rights. Loans are sized on a multiple of trailing royalty income or a loan to value against an independent valuation, combined with a minimum coverage test on projected cash flow. Structures commonly include cash sweeps if income falls below projections, amortization tied to decay, reserve accounts and audit rights over licensees. Underwriters examine historical income by title or product, concentration in the top earners, the age profile of the portfolio and the strength of the rights documentation. A conservative lender sizes debt to the long tail income rather than to recent peaks.

Valuing a royalty stream with a decay curve and terminal value

1. Year 1 royalty income is $1,000,000. Decay is 20% in year 2, 15% in year 3, 10% in year 4 and 5% in year 5, giving $800,000, $680,000, $612,000 and $581,400.
2. Discounting at 10%, the present value of years 1 through 5 is about $909,091 + $661,157 + $510,894 + $418,004 + $361,004 = about $2,860,150.
3. After year 5, income declines 3% per year forever. Terminal value at year 5 = $581,400 x 0.97 / (0.10 + 0.03) = $563,958 / 0.13 = $4,338,138.
4. Present value of terminal value = $4,338,138 / 1.10^5 = about $2,693,643.
5. Total value = $2,860,150 + $2,693,643 = about $5,553,793, or about 5.6x year 1 income. Terminal value contributes about 49% of the total.

How underwriters apply this

• Segment the portfolio by age and asset type and apply a separate decay curve to each segment.
• Confirm chain of title, reversion rights and audit rights before relying on any projection.
• Evaluate the discount rate and decay assumptions together and cross check the implied income multiple.
• Stress the long term decline rate and report the share of value from terminal value.
• Size debt to long tail income with cash sweeps tied to underperformance.
• Identify concentration in top earning titles or products and model their loss.

Frequently asked questions

Keep reading

Educational content written by practitioners. Not investment, accounting, legal or tax advice.